Filter by: patients
Home > Evaluations from Patients who take MS Phase 3 Study Fingolimod FREEDOMS II

MS Phase 3 Study Fingolimod FREEDOMS II Treatment Report

Category: Others

true

Generic Name: FTY720 (Fingolimod) Clinical Trial

See also: Clinical Trial

Sort by: Helpfulness | Most Recent

1 patient evaluation for MS Phase 3 Study Fingolimod FREEDOMS II

Purposes: Transplant rejection prevention and MS (Multiple Sclerosis) (Started Oct 27, 2008)
Date Dosage Transplant rejection prevention Perceived effectiveness MS (Multiple Sclerosis) Perceived effectiveness Side Effects Adherence Burden
Jan 24, 2011   ?Can't tell NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Nov 08, 2010 0.5 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4Major NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways A littleA littleA littleA littleA little
Date
Jan 24, 2011
Advice & Tips
Trial from Oct 08-Jan 11. Easy oral med to take (no shots!). Little to no side effects.
Cost
< $25 monthly
  • Icon_thumb_off 0 helpful marks

1 additional evaluation for MS Phase 3 Study Fingolimod FREEDOMS II is not currently shared publicly.